MEDMIRA INC (MIR.CA) Stock News

Canada - TSX-V:MIR - CA58501R1029 - Common Stock

0.07 CAD

0 (0%)

Last: 11/17/2025, 7:00:00 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

MIR.CA Latest News, Press Relases and Analysis

All

Press Releases

3 months ago - By: ACCESS Newswire

Health Canada Approves MedMira's Reveal(R) Rapid TP Test - Urgent New Tool In The Battle Against Syphilis

4 months ago - By: ACCESS Newswire

MedMira Announces Launch of Clinical Trial for Its Multiplo(R) TP/HIV Self-Test in Canada

5 months ago - By: ACCESS Newswire

MedMira Reports Second Quarter Results FY2025

7 months ago - By: ACCESS Newswire

MedMira Inc. and Lovell Announce Partnership to Increase Access to Reveal(R) G4 HIV-1/2 rapid test for VA, Department of Defense

8 months ago - By: ACCESS Newswire

MedMira Reports Second Quarter Results FY2025

9 months ago - By: ACCESS Newswire

MedMira Announces Partnership with MediGroup Physician Services in the United States

9 months ago - By: ACCESS Newswire

MedMira Announces Exclusive Distribution Agreement with Trimedic Inc. for Canada

10 months ago - By: ACCESS Newswire

MedMira Receives Investigational Testing Authorizations for Multiplo(R) TP/HIV Self-Test and Non-Professional Use Applications

3 years ago - By: Maternova, Inc. - Mentions: TSX

Maternova and MedMira Enter Distribution Agreement to Market Rapid Diagnostics for HIV, Syphilis and Hepatitis

3 years ago - By: MedMira Inc.

MedMira Strengthens and Expands Board

3 years ago - By: MedMira Inc.

MedMira Reports Third Quarter Results FY2022

3 years ago - By: MedMira Inc.

MedMira Receives Patent for its Unique Quantitative Diagnostic System